Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of UiPath Inc (NYSE: PATH) was $18.03 for the day, down -3.53% from the previous closing price of $18.69. In other words, the price has decreased by -$3.53 from its previous closing price. On the day, 22.26 million shares were traded. PATH stock price reached its highest trading level at $18.95 during the session, while it also had its lowest trading level at $17.92.
Ratios:
Our analysis of PATH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.13. For the most recent quarter (mrq), Quick Ratio is recorded 2.54 and its Current Ratio is at 2.54. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on October 02, 2025, Reiterated its Market Perform rating but revised its target price to $13 from $12.50 previously. BMO Capital Markets reiterated its Market Perform rating for the stock on September 05, 2025, while the target price for the stock was revised from $15.50 to $12.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 11 ’25 when Dines Daniel sold 45,000 shares for $18.56 per share. The transaction valued at 835,254 led to the insider holds 29,063,585 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $837,482 on Dec 10 ’25. The CEO and Chairman now owns 29,108,585 shares after completing the transaction at $18.61 per share. On Dec 09 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $19.13 each. As a result, the insider received 861,070 and left with 29,153,585 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 9641537536 and an Enterprise Value of 8325359616. As of this moment, UiPath’s Price-to-Earnings (P/E) ratio for their current fiscal year is 42.52, and their Forward P/E ratio for the next fiscal year is 23.79. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.24 while its Price-to-Book (P/B) ratio in mrq is 5.01. Its current Enterprise Value per Revenue stands at 5.36 whereas that against EBITDA is 228.876.
Stock Price History:
The Beta on a monthly basis for PATH is 1.08, which has changed by 0.28693795 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $19.84, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is 17.26%, while the 200-Day Moving Average is calculated to be 41.82%.
Shares Statistics:
PATH traded an average of 25.21M shares per day over the past three months and 31610350 shares per day over the past ten days. A total of 460.35M shares are outstanding, with a floating share count of 412.11M. Insiders hold about 23.11% of the company’s shares, while institutions hold 56.25% stake in the company. Shares short for PATH as of 1764288000 were 48479105 with a Short Ratio of 1.92, compared to 1761868800 on 47854998. Therefore, it implies a Short% of Shares Outstanding of 48479105 and a Short% of Float of 13.22.
Earnings Estimates
As of right now, 18.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.15, with high estimates of $0.19 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.69 and $0.63 for the fiscal current year, implying an average EPS of $0.67. EPS for the following year is $0.76, with 21.0 analysts recommending between $0.94 and $0.65.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 15 analysts. It ranges from a high estimate of $466.3M to a low estimate of $464M. As of. The current estimate, UiPath Inc’s year-ago sales were $423.65MFor the next quarter, 15 analysts are estimating revenue of $392.17M. There is a high estimate of $407.34M for the next quarter, whereas the lowest estimate is $380.69M.
A total of 17 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.6B, while the lowest revenue estimate was $1.59B, resulting in an average revenue estimate of $1.59B. In the same quarter a year ago, actual revenue was $1.43BBased on 19 analysts’ estimates, the company’s revenue will be $1.74B in the next fiscal year. The high estimate is $1.77B and the low estimate is $1.72B.
